On 21 May at 10.00 a seminar will take place at the Latvian Organic Synthesis Institute (OSI), Aizkraukles iela 21, Riga (From Hit Compound to Clinical Trials). The event focuses on the commercialisation of biotechnology and the drug development pathway from laboratory discovery to clinical trials.
The seminar will be chaired by DrScott Dax- an internationally renowned expert with more than 25 years of experience in R&D management in both large pharmaceutical companies and innovative biotechnology firms. His professional activities span chemistry, drug discovery, pharmacology, technology and intellectual property.
Seminar programme:
09:50 - Registration
10:00 - Introduction
10:05 - Lecture by Dr. Dax
10:50 - Q&A session
11:25 - Networking
Working language: english
The workshop is aimed at researchers, students and others interested in the development and commercialisation of medicine. Researchers planning to submit projects under the BioPhoT platform - "Biomedical and Photonics Research Platform for Innovative Products" - are particularly invited to attend.
Registration is required for the seminar: https://lu.ma/uvhdn7em
The event is funded by the Long-term National Research Programme project "BioPhoT" or "Biomedical and Photonics Research Platform for Innovative Products" (project No IVPP-EM-Innovation-2024/1-0002).
